We deeply appreciate valuable comments of the author [1] on our clinical study entitled "Predictive value of admission red cell distribution widthplatelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention" [2] . Although providing epicardial coronary vessel patency, primary percutaneous coronary intervention (pPCI) may not achieve restoration of optimal myocardial reperfusion within the myocardial tissue, a failure at the microvascular level known as no-reflow (NR) [3] . Despite achievement of optimal epicardial coronary flow in the majority of patients treated for ST segment elevation myocardial infarction (STEMI) by pPCI, myocardial NR is a commonly encountered phenomenon occurring in 5% to 50% of those patients [3] . The 'no-reflow' phenomenon in patients with STEMI is associated with a worse prognosis at short-and long-term follow-up periods [4] . Whatever the diagnostic method used, one should take into consideration the dynamic nature of NR. Indeed, NR may persist up to 48 h after reperfusion, although this timeframe is somewhat hypothetical [4] . On the other hand, a transient slowing of myocardial blood flow in the infarcted area could not be analyzed as easily as a fixed obstruction of the myocardial microvasculature.
In the previously published clinical studies, NR has often been defined as a Thrombolysis in Myocardial Infarction (TIMI) flow grade £ 2 in the absence of macrovascular obstruction [5] [6] [7] [8] [9] [10] [11] . Concordantly, NR was defined as TIMI flow grades 0-2 (no-reflow group) and reflow was defined as TIMI 3 flow grade in our study [12] . However, microvascular perfusion may also be reduced in patients with TIMI flow grade 3 [13] . TIMI flow assessment on classical coronary angiography is a simple and easily obtained method, although it has some limitations regarding to sensitivity and specificity for the assessment of NR. Indeed, capillary blood flow is not measured directly by angiography, and a significant proportion of TIMI grade 3 flow patients actually present with NR [14] . Therefore, other angiographic measures that have been developed to assess microvascular perfusion include the TIMI frame count and myocardial blush grade (MBG) [15] . MBG is another newly developed angiographic imaging technique for assessing myocardial microvasculature and tissue reflow [13] . With this method cardiologists can assess the myocardial tissue opacification intensity with longer angiographic runs, performed until the venous phase of contrast passage. According to visual or computerized signal intensity automatic assessment, myocardial "blush" is graded according to a scale with four intensity grades: 0 -no myocardial blush; 1 -minimal myocardial blush or contrast density; 2 -moderate myocardial blush or contrast density, but less than that obtained during angiography of a contralateral non-infarct-related coronary artery; and 3 -normal myocardial blush or contrast density, similar to that obtained during angiography of a contralateral non-infarctrelated coronary artery. However, this very low contrast-to-noise imaging method of myocardial tissue opacification has the same limitations as the angiographic TIMI scale [16] . More importantly, Van't Hof et al. [13] demonstrated relatively high inter-and intra-observer variabilities of MBG in patients with STEMI (3% and 10%, respectively).
On the other hand, timing of angiography may be too early to assess myocardial reperfusion injuries and other complex phenomena occurring in the hours and days after reperfusion. Therefore, post-PCI TIMI flow or MBG are not necessarily predictive of the presence of microvascular obstruction (MVO) as detected by cardiac magnetic resonance (CMR) [16] . CMR represents the most sensitive and specific method of assessment for NR [4] . Contrast enhanced CMR can be able to identify the lack of myocardial reperfusion after STEMI. CMR also allows a complete and accurate assessment of left ventricular status in patients after STEMI. Moreover, it is able to assess both functional and structural abnormalities of coronary microvasculature through MVO study, in contrast to conventional angiography providing a functional assessment regarding myocardial blood flow. Although a grade 3 MBG or TIMI flow indicate a good prognosis at population level, up to 60% of STEMI patients with optimal angiographic reperfusion indices (MBG and TIMI flow = 3) show NR on CMR at the following 72 h on an individual basis [17] .
In addition to conventional angiographic methods, coronary Doppler flow wire can be used to assess NR. Doppler flow measurements reveal a characteristic pattern of both systolic retrograde flow and rapid deceleration of diastolic flow in vessels with NR [17] .
In conclusion, although MBG is found to be superior to TIMI flow grade for the detection of NR, it has some major limitations including very low contrast-to-noise imaging method of myocardial tissue opacification and relatively high intra-and inter-observer variabilities. On the other hand, we are convinced that TIMI flow grade assessment is more practical and swift method for NR diagnosis in catheterization laboratory when considering critical time window for the treatment.
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